Leishmania epidemiology, diagnosis, chemotherapy and vaccination approaches in the international network of Pasteur Institutes (Q44872017)

7 December 2017

Leishmania epidemiology, diagnosis, chemotherapy and vaccination approaches in the international network of Pasteur Institutes (English)

1 reference

7 December 2017

4

1 reference

7 December 2017

Eric Prina

5

0 references

author name string

Hechmi Louzir

1

1 reference

7 December 2017

Karim Aoun

2

1 reference

7 December 2017

Gerald F Späth

3

1 reference

7 December 2017

Kathleen Victoir

6

1 reference

7 December 2017

Aïda Bouratbine

7

1 reference

7 December 2017

language of work or name

French

0 references

publication date

20 December 2013

1 reference

7 December 2017

1 reference

7 December 2017

29

1 reference

7 December 2017

1151-1160

1 reference

7 December 2017

12

1 reference

Clinical spectrum of Leishmaniasis

7 December 2017

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Leishmaniasis worldwide and global estimates of its incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Phlebotomus sergenti (Parrot, 1917) identified as Leishmania killicki host in Ghardaïa, south Algeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Natural infection of North African gundi (Ctenodactylus gundi) by Leishmania tropica in the focus of cutaneous leishmaniasis, Southeast Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

First report on natural infection of Phlebotomus sergenti with Leishmania promastigotes in the cutaneous leishmaniasis focus in southeastern Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Seasonal and nocturnal domiciliary human landing/biting behaviour of Lutzomyia (Lutzomyia) evansi and Lutzomyia (Psychodopygus) panamensis (Diptera; Psychodidae) in a periurban area of a city on the Caribbean coast of eastern Venezuela (Barcelona; A

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Public health. Monitoring EU emerging infectious disease risk due to climate change

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Imported and travelling dogs as carriers of canine vector-borne pathogens in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Sandflies and leishmaniasis in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Control of neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Validation of a direct agglutination test prototype kit for the diagnosis of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Immunochromatographic rK39 strip test in the serodiagnosis of visceral leishmaniasis in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Identification and diagnostic utility of Leishmania infantum proteins found in urine samples from patients with visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Antigenuria in visceral leishmaniasis: detection and partial characterisation of a carbohydrate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Diagnosis of mediterranean visceral leishmaniasis by detection of leishmania antibodies and leishmania DNA in oral fluid samples collected using an Oracol device

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Proteomic identification of host and parasite biomarkers in saliva from patients with uncomplicated Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Phase 4 pharmacovigilance trial of paromomycin injection for the treatment of visceral leishmaniasis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Paromomycin: uptake and resistance in Leishmania donovani.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Identification of Leishmania-specific protein phosphorylation sites by LC-ESI-MS/MS and comparative genomics analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Phosphoproteomic analysis of Leishmania donovani pro- and amastigote stages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

PhosTryp: a phosphorylation site predictor specific for parasitic protozoa of the family trypanosomatidae

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

What has proteomics taught us about Leishmania development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Apoptotic marker expression in the absence of cell death in staurosporine-treated Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

The crystal structure of the MAP kinase LmaMPK10 from Leishmania major reveals parasite-specific features and regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

High content analysis of primary macrophages hosting proliferating Leishmania amastigotes: application to anti-leishmanial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Topical paromomycin with or without gentamicin for cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL/6 Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

DEAD-box proteins, like Leishmania eIF4A, modulate interleukin (IL)-12, IL-10 and tumour necrosis factor-alpha production by human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Leishmania infantum LeIF protein is an ATP-dependent RNA helicase and an eIF4A-like factor that inhibits translation in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Cell biology and immunology of Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

The immunology of susceptibility and resistance to Leishmania major in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

CD8(+) T cells in leishmania infections: friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Vaccine Development Against Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Adjuvants for Leishmania vaccines: from models to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Leishmaniasis: vaccine candidates and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

The development and clinical evaluation of second-generation leishmaniasis vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

The immune response to sand fly salivary proteins and its influence on leishmania immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Characterization of the antibody response to the saliva of Phlebotomus papatasi in people living in endemic areas of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Salivary antigen SP32 is the immunodominant target of the antibody response to Phlebotomus papatasi bites in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

Updating the salivary gland transcriptome of Phlebotomus papatasi (Tunisian strain): the search for sand fly-secreted immunogenic proteins for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

History of human parasitology

21 January 2018

1 reference

https://api.crossref.org/works/10.1051%2FMEDSCI%2F20132912020

10.1051/MEDSCI/20132912020

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

0 references

1 reference